200 related articles for article (PubMed ID: 19564365)
1. Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages.
Lemaire S; Van Bambeke F; Tulkens PM
Antimicrob Agents Chemother; 2009 Sep; 53(9):3734-43. PubMed ID: 19564365
[TBL] [Abstract][Full Text] [Related]
2. Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila.
Lemaire S; Van Bambeke F; Tulkens PM
Int J Antimicrob Agents; 2011 Jul; 38(1):52-9. PubMed ID: 21596526
[TBL] [Abstract][Full Text] [Related]
3. Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines.
Lemaire S; Van Bambeke F; Appelbaum PC; Tulkens PM
J Antimicrob Chemother; 2009 Nov; 64(5):1035-43. PubMed ID: 19759040
[TBL] [Abstract][Full Text] [Related]
4. In vitro antibacterial activity of modithromycin, a novel 6,11-bridged bicyclolide, against respiratory pathogens, including macrolide-resistant Gram-positive cocci.
Sato T; Tateda K; Kimura S; Iwata M; Ishii Y; Yamaguchi K
Antimicrob Agents Chemother; 2011 Apr; 55(4):1588-93. PubMed ID: 21220534
[TBL] [Abstract][Full Text] [Related]
5. CEM-101 activity against Gram-positive organisms.
Woosley LN; Castanheira M; Jones RN
Antimicrob Agents Chemother; 2010 May; 54(5):2182-7. PubMed ID: 20176910
[TBL] [Abstract][Full Text] [Related]
6. In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila.
Sato T; Tateda K; Kimura S; Ishii Y; Yamaguchi K
Antimicrob Agents Chemother; 2011 Apr; 55(4):1594-7. PubMed ID: 21220530
[TBL] [Abstract][Full Text] [Related]
7. Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila.
Lemaire S; Kosowska-Shick K; Appelbaum PC; Verween G; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2010 Jun; 54(6):2549-59. PubMed ID: 20385852
[TBL] [Abstract][Full Text] [Related]
8. Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin.
Imbuluzqueta E; Lemaire S; Gamazo C; Elizondo E; Ventosa N; Veciana J; Van Bambeke F; Blanco-Prieto MJ
J Antimicrob Chemother; 2012 Sep; 67(9):2158-64. PubMed ID: 22615297
[TBL] [Abstract][Full Text] [Related]
9. Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus.
Seral C; Carryn S; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2003 May; 51(5):1167-73. PubMed ID: 12697643
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells.
Lemaire S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
Antimicrob Agents Chemother; 2007 Aug; 51(8):2748-57. PubMed ID: 17548493
[TBL] [Abstract][Full Text] [Related]
11. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
Seral C; Barcia-Macay M; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2005 Apr; 55(4):511-7. PubMed ID: 15731197
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.
Barcia-Macay M; Seral C; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2006 Mar; 50(3):841-51. PubMed ID: 16495241
[TBL] [Abstract][Full Text] [Related]
13. Activity of three {beta}-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus.
Lemaire S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
J Antimicrob Chemother; 2005 Jun; 55(6):897-904. PubMed ID: 15860552
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages.
Seral C; Van Bambeke F; Tulkens PM
Antimicrob Agents Chemother; 2003 Jul; 47(7):2283-92. PubMed ID: 12821480
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.
Farrell DJ; Sader HS; Castanheira M; Biedenbach DJ; Rhomberg PR; Jones RN
Int J Antimicrob Agents; 2010 Jun; 35(6):537-43. PubMed ID: 20211548
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila.
Baltch AL; Smith RP; Ritz WJ; Franke MA; Michelsen PB
J Antimicrob Chemother; 2000 Jul; 46(1):51-5. PubMed ID: 10882688
[TBL] [Abstract][Full Text] [Related]
17. The effect of azithromycin on intracellular Legionella pneumophila in the Mono Mac 6 cell line at serum concentrations attainable in vivo.
Jonas D; Engels I; Daschner FD; Frank U
J Antimicrob Chemother; 2000 Sep; 46(3):385-90. PubMed ID: 10980164
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of macrolides against intracellular Legionella pneumophila.
Segreti J; Meyer P; Kapell K
Diagn Microbiol Infect Dis; 1996 Jul; 25(3):123-6. PubMed ID: 8902407
[TBL] [Abstract][Full Text] [Related]
19. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
Stout JE; Sens K; Mietzner S; Obman A; Yu VL
Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
[TBL] [Abstract][Full Text] [Related]
20. Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila.
Jung R; Danziger LH; Pendland SL
J Antimicrob Chemother; 2002 May; 49(5):857-61. PubMed ID: 12003984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
